NO991161D0 - TNF <beta> -like protein for the treatment of prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods - Google Patents

TNF <beta> -like protein for the treatment of prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods

Info

Publication number
NO991161D0
NO991161D0 NO991161A NO991161A NO991161D0 NO 991161 D0 NO991161 D0 NO 991161D0 NO 991161 A NO991161 A NO 991161A NO 991161 A NO991161 A NO 991161A NO 991161 D0 NO991161 D0 NO 991161D0
Authority
NO
Norway
Prior art keywords
tnf
beta
protein
treatment
nucleic acid
Prior art date
Application number
NO991161A
Other languages
Norwegian (no)
Other versions
NO991161L (en
NO324815B1 (en
Inventor
Mark Erlander
Shaoming Huang
Michael Jackson
Per Peterson
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO991161D0 publication Critical patent/NO991161D0/en
Publication of NO991161L publication Critical patent/NO991161L/en
Publication of NO324815B1 publication Critical patent/NO324815B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
NO19991161A 1996-09-11 1999-03-10 Use of a TNF-beta-like protein, or a DNA or RNA molecule encoding the same, for the preparation of a preparation for the treatment of androgen-independent prostate cancer NO324815B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2592396P 1996-09-11 1996-09-11
PCT/US1997/016191 WO1998011224A1 (en) 1996-09-11 1997-09-11 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods

Publications (3)

Publication Number Publication Date
NO991161D0 true NO991161D0 (en) 1999-03-10
NO991161L NO991161L (en) 1999-05-07
NO324815B1 NO324815B1 (en) 2007-12-10

Family

ID=21828810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991161A NO324815B1 (en) 1996-09-11 1999-03-10 Use of a TNF-beta-like protein, or a DNA or RNA molecule encoding the same, for the preparation of a preparation for the treatment of androgen-independent prostate cancer

Country Status (12)

Country Link
US (1) US6107476A (en)
EP (1) EP0950105A1 (en)
JP (1) JP2001500732A (en)
KR (1) KR20000038040A (en)
CN (1) CN1233289A (en)
AU (1) AU735776B2 (en)
BR (1) BR9711763A (en)
CA (1) CA2265444C (en)
IL (2) IL128872A0 (en)
NO (1) NO324815B1 (en)
NZ (1) NZ334592A (en)
WO (1) WO1998011224A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521227B1 (en) 1999-11-18 2003-02-18 Peter L. Hudson Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
US5994102A (en) * 1994-12-15 1999-11-30 Human Genome Sciences, Inc. Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
US6524802B1 (en) * 1996-03-29 2003-02-25 The Johns Hopkins University School Of Medicine Methods of detecting growth differentiation factor-14
US6465181B2 (en) * 1999-03-25 2002-10-15 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
JP2002543841A (en) * 1999-05-17 2002-12-24 バイオファーム ゲゼルシャフト ツア バイオテクノロジシェン エントヴィックルング ウント ツム フェルトリーブ フォン ファルマカ エムベーハー Neuroprotective properties of GDF-15, a new member of the TGF-β superfamily
US7141661B2 (en) 2000-09-08 2006-11-28 The United States Of America As Represented By The Department Of Health And Human Services Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
US20070237713A1 (en) * 2006-04-04 2007-10-11 Fan Rong A PCan065 Antibody Compositions and Methods of Use
US9550819B2 (en) * 2012-03-27 2017-01-24 Ngm Biopharmaceuticals, Inc. Compositions and methods of use for treating metabolic disorders
CA2899170C (en) 2013-01-30 2022-08-02 Ngm Biopharmaceuticals, Inc. Compositions and methods of use in treating metabolic disorders
US9161966B2 (en) 2013-01-30 2015-10-20 Ngm Biopharmaceuticals, Inc. GDF15 mutein polypeptides
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
WO2016018931A1 (en) 2014-07-30 2016-02-04 Ngm Biopharmaceuticals, Inc. Compositions and methods of use for treating metabolic disorders
AU2015339130C1 (en) 2014-10-31 2021-03-18 Ngm Biopharmaceuticals, Inc. Compositions and methods of use for treating metabolic disorders
PE20190126A1 (en) 2016-03-31 2019-01-17 Ngm Biopharmaceuticals Inc BINDING PROTEINS AND METHODS OF USING THEM

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
CA1340740C (en) * 1987-12-08 1999-09-14 Eileen R. Mulvihill Co-expression in eukaryotic cells
JPH07250688A (en) * 1994-01-28 1995-10-03 Sagami Chem Res Center New human c-dna coding tgf-beta superfamily protein
JPH07258293A (en) * 1994-03-23 1995-10-09 Asahi Chem Ind Co Ltd New protein and its production
WO1996018730A1 (en) * 1994-12-15 1996-06-20 Human Genome Sciences, Inc. Prostatic growth factor
AU711368B2 (en) * 1995-06-22 1999-10-14 St Vincent's Hospital Sydney Limited Novel TGF-beta like cytokine
WO1997000958A1 (en) * 1995-06-22 1997-01-09 St. Vincent's Hospital Sydney Limited NOVEL TGF-β LIKE CYTOKINE
US6524802B1 (en) * 1996-03-29 2003-02-25 The Johns Hopkins University School Of Medicine Methods of detecting growth differentiation factor-14

Also Published As

Publication number Publication date
NZ334592A (en) 2000-10-27
IL128872A0 (en) 2000-01-31
US6107476A (en) 2000-08-22
AU4344297A (en) 1998-04-02
CA2265444A1 (en) 1998-03-19
IL128872A (en) 2009-08-03
BR9711763A (en) 1999-08-24
NO991161L (en) 1999-05-07
NO324815B1 (en) 2007-12-10
EP0950105A1 (en) 1999-10-20
JP2001500732A (en) 2001-01-23
CN1233289A (en) 1999-10-27
CA2265444C (en) 2008-11-18
AU735776B2 (en) 2001-07-12
KR20000038040A (en) 2000-07-05
WO1998011224A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
NO991161L (en) TNF &lt;beta&gt; -like protein for the treatment of prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
NO986089D0 (en) Methods and preparations for the treatment of tumors, tumor-related diseases and o
ATE282434T1 (en) A COMPOSITION CONTAINING A DETERGENT AND AN ADENOVIRAL VECTOR ENCODING A TUMOR SUPPRESSOR GENE
HUP9901321A3 (en) Methods and compositions for determining the sequence of nucleic acid molecules
NO326660B1 (en) Imidazolyl-cyclic acetal compounds, pharmaceutical compositions containing these compounds and use of the compounds
BR9808881A (en) Compounds for prostate cancer immunotherapy and methods for their use
WO2001072962A3 (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
EE200100717A (en) Indazole Compounds and Pharmaceutical Compositions for the Inhibition of Protein Kinases and Methods for their Use
NO994778D0 (en) Methods and compositions for the treatment of intestinal inflammation
FI973467A (en) DNA molecules, preparation and use in gene therapy
FR2707882B1 (en) New protein anti-mediator therapeutic kits, preparation process and pharmaceutical compositions containing them.
HK1030144A1 (en) Method for treatment of liver tumours and pharmaceutical compositions for use therein.
BR9711296A (en) Compound therapeutic process to inhibit the growth of cancer cells and pharmaceutical composition
NO20015828D0 (en) Methods for Preparation of 5 &#39;Nucleic Acid Protein Conjugates
AU3510200A (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
NO986177D0 (en) Method of Preparation of Therapeutic DNA
DK1117661T3 (en) Propanolamine derivatives substituted with heterocyclic groups, process for their preparation, pharmaceutical preparations containing these compounds and their use
HUP0302913A3 (en) Methods of inducing cancer cell death and tumor regression and preparation of pharmaceutical compositions suitable for treating the same
DE60037978D1 (en) INTERFERON SIMILAR MOLECULES AND THEIR USES
WO1999002704A3 (en) Dual specifically phosphatase and methods of use
EE200000333A (en) Conjugate and Pharmaceutical Composition for the Treatment of Prostate Cancer and Methods for its Preparation
WO2000078795A3 (en) Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1)
DE69916488D1 (en) SUBSTITUTED CAPROLACTAM DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT OF TUMORS
EP0910669A4 (en) Isolated nucleic acid molecules which are members of the mage-b family and uses thereof
NO993784L (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine

Legal Events

Date Code Title Description
MK1K Patent expired